COVID19 is a menacing matador

Malavan Ragulojan, c2022 This article was written on March 15th, 2020 What a week for global markets. On March 14th, the longest bull market run in American history finally came to a dramatic close as the WHO declared COVID19 a pandemic on March 11th, and President Trump announced the virus to be a national emergency. […]

Read More COVID19 is a menacing matador

CAR T-Cell Therapy Comes to Hamilton Health Sciences

By: Michael Coomber (c2022) In 2017, the FDA approved a new class of onco-immunotherapies for the treatment of B-cell acute lymphoblastic leukemia and B-cell non-Hodgkin lymphomas. Initial trials of these CAR T-cell therapies produced remarkable rates of remission, often in treatment-resistant individuals, despite causing life-threatening adverse effects in a subset of patients. Advancements in CAR […]

Read More CAR T-Cell Therapy Comes to Hamilton Health Sciences